Illumina Total product revenue — Cost of revenue decreased by 12.5% to $273.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 7.9%, from $253.00M to $273.00M. Over 4 years (FY 2021 to FY 2025), Total product revenue — Cost of revenue shows relatively stable performance with a 1.1% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase in cost relative to product revenue may signal supply chain inefficiencies or rising manufacturing costs, while a decrease suggests improved production margins or economies of scale.
This metric represents the direct costs associated with manufacturing and delivering the company's physical products, in...
Comparable to cost of goods sold (COGS) for hardware-centric segments in the medical device and biotechnology equipment sectors.
ilmn_segment_total_product_revenue_cost_of_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $254.00M | $264.00M | $278.00M | $299.00M | $286.00M | $280.00M | $278.00M | $285.00M | $305.00M | $293.00M | $293.00M | $255.00M | $250.00M | $235.00M | $278.00M | $253.00M | $276.00M | $267.00M | $312.00M | $273.00M |
| QoQ Change | — | +3.9% | +5.3% | +7.6% | -4.3% | -2.1% | -0.7% | +2.5% | +7.0% | -3.9% | +0.0% | -13.0% | -2.0% | -6.0% | +18.3% | -9.0% | +9.1% | -3.3% | +16.9% | -12.5% |
| YoY Change | — | — | — | — | +12.6% | +6.1% | +0.0% | -4.7% | +6.6% | +4.6% | +5.4% | -10.5% | -18.0% | -19.8% | -5.1% | -0.8% | +10.4% | +13.6% | +12.2% | +7.9% |